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ABSTRACT
Microarray analyses of mRNAs over-expressed in
strains lacking the nuclear exosome component
Rrp6 identified the transcript encoding the ARE-
binding protein Cth2, which functions in cytoplasmic
mRNA stability. Subsequent northern analyses
revealed that exosome mutants accumulate a
3’-extended transcript at the expense of the mature
CTH2 mRNA. The 3’ ends of the CTH2 mRNA were
mapped to a [GU3–5]5 repeat, unlike any previously
characterized polyadenylation site. CTH2 mRNA
accumulation was not inhibited by mutations in
3’-cleavage and polyadenylation factors, Rna14,
Rna15 and Pap1, which block accumulation of
other mRNAs. The 3’-extended CTH2 pre-mRNA
strongly accumulated in strains with mutations in
the TRAMP4 polyadenylation complex or the Nrd1/
Nab3/Sen1 complex, and contains multiple Nrd1 and
Nab3 binding sites. CTH2 carries a consensus ARE
element and levels of the pre-mRNA andmRNAwere
elevated bymutation of the ARE or inactivation of the
nuclear 5’-exonuclease Rat1. We propose that CTH2
mRNA is processed from a 3’-extended primary
transcript by the exosome, TRAMP and Nrd1/Nab3/
Sen1 complexes. This unusual pathway may allow
time for nuclear, ARE-mediated regulation of CTH2
levels involving Rat1.
INTRODUCTION
The exosome is a complex with 30-50 exonuclease activity
that has been implicated in the processing and degradation
of many diﬀerent RNA species (1). The complex contains
10 essential components, often termed the core exosome
that are common to the nuclear and cytoplasmic forms of
the exosome. This can associate with the 30-exonuclease
Rrp6 in the nucleus and with the GTPase Ski7 in the
cytoplasm. Known substrates include mRNA precursors
that have failed to undergo normal co-transcriptional
cleavage and polyadenylation due to mutations in the
Rna14 and Rna15 components of the cleavage and poly-
adenylation machinery (2). Previous analyses by transcrip-
tion run on had shown that under these circumstances,
RNA polymerase II (Pol II) generates long 30-extended
transcripts (3); however, these were essentially undetectable
by northern hybridization in the single mutant strains,
presumably due to their rapid degradation. The long
30-extended species were greatly stabilized by the combina-
tion of rna14-1 and rna15-2 mutations with depletion of
components of the core exosome or the putative RNA
helicase Mtr4. The Trf4/5, Air1/2, Mtr4 polyadenylation
(TRAMP) complexes function together with the exosome
in the degradation of many diﬀerent transcripts (1). These
observations therefore suggested that the aberrant
30-extended pre-mRNAs were recognized and very rapidly
degraded by the TRAMP/exosome system.
An unexpected feature of these analyses was the ﬁnding
that synthesis of functional mRNAs in rna14-1 strains
could largely be restored by loss of the nuclear-speciﬁc
exosome component Rrp6 (2). This indicated that func-
tional mRNAs could be generated by exonuclease diges-
tion by the exosome, followed by polyadenylation that
was uncoupled from co-transcriptional cleavage by the
cannonical mRNA cleavage and polyadenylation system.
This suggested the existence of a novel 30-processing
pathway for mRNA synthesis, but no mRNAs were
known that followed this pathway.
There has been extensive analysis of the regulation of
mRNA levels by cytoplasmic mRNA turnover. However,
we previously speculated that a class of mRNAs might be
regulated by exosome-mediated RNA degradation within
the nucleus. With the aim of identifying such mRNAs we
conducted microarray analyses on strains lacking the
nuclear-speciﬁc exosome component Rrp6, or carrying
conditional mutations in the core exosome component
Rrp41/Ski6 or the nuclear exosome co-factor Nrd1 (4).
Amongst the up-regulated transcripts identiﬁed was the
CTH2 mRNA, which we selected for further analysis.
Cth2 and Cth1 are yeast homologues of the human zinc
ﬁnger protein tristetraprolin (TTP)/Tis11, which is known
to be involved in the activated mRNA degradation
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pathway, ARE-mediated decay (5). This pathway targets
mRNAs containing an A+U rich sequence element
(ARE), generally localized in the 30 UTR, which is the
binding site for TTP and several other human proteins.
Human ARE-containing mRNAs encode many proteins
that function as growth factors, expression of which must
be very tightly controlled. Under normal growth condi-
tions, TTP binding promotes the rapid degradation of
ARE-containing mRNAs. However, under stress condi-
tions the stability and translation of ARE-containing
mRNAs can be speciﬁcally enhanced (6), showing these to
be versatile regulatory elements. Characterized ARE-
binding proteins associate with pre-mRNAs in the nucleus
and are exported to the cytoplasm in complex with the
mRNA. It has been generally assumed that ARE-mediated
decay is a cytoplasmic process, but this has not been
assessed for most substrates. Insertion of an ARE into the
U1 small nuclear RNA resulted in its destabilization (7),
but the localization of degradation was not tested.
In yeast, the identiﬁed targets of Cth2 are mRNAs
encoding proteins involved in iron (Fe) metabolism (8).
Under conditions of Fe deﬁciency, Cth2 binds to and
stimulates the degradation of many mRNAs that encode
proteins involved in pathways that require Fe availability.
Human TTP is auto-regulated via a consensus ARE in the
30 UTR of its own mRNA. This has not been assessed for
yeast CTH2, but inspection of the sequence of the 30-UTR
reveals the presence of a perfect consensus ARE sequence
(UUAUUUAUU), and deletion of the gene encoding
Cth1 up-regulates CTH2 mRNA levels (9).
Here, we report that CTH2 mRNA has a novel
biosynthetic pathway and appears to be subject to ARE-
mediated regulation in the nucleus.
MATERIAL AND METHODS
Strains, culture, media and yeast genetics
Strains were grown in YPD medium containing 2%
peptone, 1% yeast extract and 2% glucose or YNB
medium containing 0.67% yeast nitrogen base, 0.5%
ammonium sulphate, 2% glucose and supplemented with
the required amino acids. Strains used in this study are
listed in Supplementary Table S1. Transformation was
performed as described (10). Half-lives of the (mini-PGK1/
CTH2-30-UTR) reporter constructs were determined by
adding doxycycline to a ﬁnal concentration of 2 mgml–1 to
inhibit transcription before harvesting samples at diﬀerent
time points.
RNA extraction and northern hybridization
RNA extractions were made as previously described (11).
Twenty micrograms of total RNA for each sample were
analysed on glyoxal–agarose gels (12). Analyses of reporter
construct expression were made by resolving 7 mg of total
RNA on a 6% polyacrylamide/8.3M urea gel. Random
primed probes of the coding sequence of CTH2 mRNA,
made with Ambion Strip-EZ DNAKit, were used to detect
both mature and pre-CTH2 mRNA species. Other oligo-
nucleotides used are listed in Supplementary Table S2.
Hybridization was performed using Ambion ULTRAhyb
or ULTRAhyb–Oligo according to the manufacturer’s
conditions.
Plasmid constructions, cloning and mutagenesis
The mini-PGK1 construct used (13) was cloned under the
control of a tetoﬀ promoter in the pCM189 plasmid after
removal of the CYC1 transcriptional terminator. The
mini-PGK1 30-UTR was removed and replaced by the
2000-nt downstream of the stop codon of CTH2 [see
Figure 4C for structure of the (Mini-PGK1/CTH2-30-
UTR) plasmid]. The ARE sequence AUUUA located
51–55 after the translation stop codon was mutated to
AGGUA by directed mutagenesis with oligonucleotides
listed in Supplementary Table S2.
RNase H treatment
Deadenylation was performed essentially as described (14).
Samples (20mg) of RNA were annealed with a gene-
speciﬁc primer located 161–180 nt 30 to the stop codon
(Supplementary Table S2), with or without 400 ng
oligo(dT) for 10min at 688C and digested with 1.5U
RNase H at 308C for 1 h.
3’-end rapid amplification of cDNA ends (RACE) and PCR
To map the CTH2 poly(A) site, 5 mg of wild-type mRNA
were reverse transcribed with superscript II RT for 50min
at 448C in presence of the oligo V(T)25-Adaptor. cDNA
was then ampliﬁed with a reverse adaptor oligonucleotide
and a forward oligonucleotide at the end of the coding
sequence (Cth2-CDS-F-750). A second round of PCR
ampliﬁcation was performed with a forward oligonucleo-
tide located 30-nt downstream (Cth2-CDS-F-780). After
gel puriﬁcation, PCR products were cloned into pGEM-T
and 19 clones were sequenced. The same procedure was
used to characterize the end of the 30-extended transcript,
using tfr4 mRNA, V(T)25-Adaptor oligonucleotide for
the reverse transcription and forward primers Cth2-30-
UTR-F-1300 and Cth2-30-UTR-F-1350, with the reverse
adaptor oligonucleotide for the nested-PCR. To charac-
terize the presence of an extended transcript (Figure 2), we
reverse transcribed 5 mg of wild-type mRNA or tfr4
mRNA in presence of random hexanucleotides. Primers
Cth2-CDS-F-750 and Cth2-30-UTR-R-1340, located on
either side of the predicted poly(A) site were used for the
PCR reaction. Oligonucleotide sequences are listed in
Supplementary Table S2.
RESULTS
Synthesis ofCTH2mRNA does not require the activity
of the normal cleavage and polyadenylation machinery
The 30 ends of almost all characterized yeast mRNAs are
generated by co-transcriptional cleavage and coupled
polyadenylation. To test whether this is also the case for
CTH2, we tested temperature-sensitive lethal (ts-lethal)
mutations in the Rna14 and Rna15 components of
cleavage factor 1 (CF1) and the poly(A) polymerase
Pap1 (Figure 1A). Transfer of rna14-1, rna15-2, pap1-2 or
pap1-5 strains to the non-permissive temperature (378C)
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for 1 h led to the complete loss of RPL30 mRNA, as
expected. Strikingly, accumulation of the CTH2 mRNA
was not abolished in the mutant strains at 378C and,
indeed, the levels were elevated relative to 238C.
In the rna14-1, pap1-2 and pap1-5 strains the migration
of CTH2 mRNA appeared faster than in the wild-type at
378C, suggesting that deadenylated mRNA was accumu-
lated (Figure 1A). To conﬁrm this conclusion, we per-
formed oligonucleotide directed RNase H cleavage
(Figure 1B) on RNA extracted from the rna14-1, rna15-2
and pap1-5 strains 1 h after transfer to 378C. All samples
were cleaved with an oligo positioned 50-nt 50 to the
estimated 30 end of the mature CTH2 mRNA, to release a
smaller 30 fragment of the mRNA, and in the presence or
absence of oligo(dT) to remove the poly(A) tail. This
experiment conﬁrmed that a deadenylated form of CTH2
mRNA accumulated in rna14-1 and pap1-5 strains at non-
permissive temperature, whereas CTH2 mRNA was
polyadenylated in the rna15-2 strain.
These results indicated that 30 end formation on CTH2
mRNA does not require the normal activity of Rna14 or
Rna15, which are necessary for the stable accumulation of
many diﬀerent mRNA previously tested. Formation of the
poly(A) tail requires the activities of Rna14 and Pap1 but,
unusually, polyadenylation is also not required for CTH2
mRNA accumulation. In the mRNA 30 processing
mutants, theCTH2mRNA level was substantially elevated
at 378C relative to 238C. Under these conditions, almost all
other newly synthesized pre-mRNAs are being degraded
by the RNA surveillance system, and this competition may
reduce turnover of CTH2 mRNA.
These analyses indicated that 30-end formation onCTH2
was diﬀerent from other characterized mRNAs. We
therefore identiﬁed the polyadenylation site of the mature
CTH2 mRNA transcript by 30-end RACE to determine
whether this also showed unusual features (Figure 1C).
PCR products were cloned in pGEM-T and 19 clones were
sequenced; the 17 relevant clones each identiﬁed poly(A)
sites located within a [GU3–5]5 repeat sequence, with most
transcripts terminating between the third and the fourth
repeats.
To assess whether the 30 ends of the CTH2 mRNA were
generated by transcription termination, the [GU3–5]5
sequence and 40 nt of ﬂanking sequence were inserted
into the 30 ﬂanking region of a mini-PGK1 reporter (see
below). Discrete 30 ends were not detected in the vicinity of
the [GU3–5]5 element (data not shown), indicating that it
does not function as a transcription terminator.
The [GU3–5]5 repeat is unrelated to the consensus site
for cleavage and poly(A) or any other characterized site of
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mRNA polyadenylation in yeast. Moreover, the ﬂanking
region also lacks sequence features expected at yeast
poly(A) sites. These generally include a positioning ele-
ment (PE) comprised of AAUAAA and related sequences,
and an eﬃciency element that acts as a binding site for
Nab4 (also known as Hrp1). In CTH2 a potential binding
site for Nab4 (15) is located 40-nt 50 to the [GU3–5]5
element but we could not detect any evident PE.
CTH2mRNA can be generated from a 3’-extended precursor
Our data indicated that the 30 ends of the mature CTH2
transcripts are not generated by conventional
co-transcriptional cleavage by the polyadenylation
machinery, which suggested that longer 30-extended
transcripts would be detectable in wild-type strains. This
was assessed by RT–PCR using primers on either side of
the 30 end of the mature mRNA. The forward primer is
located just before the stop codon within the ORF,
whereas the reverse primer is located 1300-nt 30 to the stop
codon (Figure 2A). The RT–PCR product was detected in
the wild-type strain, showing that a non-cleaved CTH2
transcript extends at least 1.3 kb beyond the 30 end of the
mRNA (Figure 2B). The PCR product is speciﬁc because
it was not detected in a RT minus sample or in RNA
extracted from a CTH2 strain. Consistent with data
presented below, the signal was elevated in a strain lacking
the Trf4 component of the TRAMP4 complex.
Our previous microarray analysis (4) indicated that the
abundance of the CTH2 mRNA was elevated in strains
lacking the nuclear-speciﬁc exosome component Rrp6
compared to the wild-type. This result suggested that
CTH2 mRNA expression might be regulated by nuclear
degradation (4). To test this hypothesis, we examined
CTH2 mRNA expression by northern hybridization in
strains with defects in the activity of the nuclear exosome.
The rrp6 strain showed levels of mature CTH2mRNA
that were similar to wild-type, but accumulated an exten-
ded transcript of about 2.8 kb in length plus a smear of
intermediate-sized RNAs (Figure 3A). The extended RNA
species were detectable at low levels in the wild-type,
consistent with the RT–PCR data. The TRAMP com-
plexes function together with the nuclear exosome in the
degradation of many RNA substrates, and we therefore
also analysed strains lacking TRAMP components. The
30-extended, 2.8-kb CTH2 RNA accumulated in strains
with a double deletion for the functionally redundantAIR1
and AIR2 genes and in a trf4 strain lacking the poly(A)
polymerase from the TRAMP4 complex (Figure 3A).
In contrast, no accumulation of the extended transcripts
was detected in a trf5 strain lacking the poly(A)
polymerase from the TRAMP5 complex (Figure 3A).
The DEVH-box, putative RNA helicase Mtr4 is common
to both the TRAMP4 and TRAMP5 complexes, and is
essential for viability. A conditional GAL::mtr4 strain was
therefore depleted of Mtr4 by growth on glucose medium
(Figure 3B). The extended CTH2 transcript was accumu-
lated, also accompanied by substantial loss of the mature
mRNA (Figure 3B). In addition, strong accumulation was
seen for CTH2 RNA fragments, mostly shorter than the
mRNA. A very similar phenotype was seen for a
conditional GAL::rrp41 strain depleted of the core
exosome component Rrp41. Strains with ts-lethal muta-
tions in core exosome components, mtr3-1, rrp4-1 and
rrp44-1 also showed accumulation of 30 extended CTH2
mRNA (data not shown). In contrast, no eﬀects on CTH2
were seen in a ski7 strain that lacks a cytoplasmic
exosome component (Figure 3C).
Levels of mature CTH2 mRNA were much more
strongly aﬀected in the PGAL-MTR4 strain than trf4.
This suggests that Trf5, and therefore the TRAMP5
complex, may participate in degradation of pre-CTH2, at
least in the absence of Trf4. However, processing of
several characterized exosome substrates, notably the
precursors to the 5.8S rRNA, strictly require the activity
of Mtr4, but do not clearly involve the TRAMP com-
plexes. Mtr4 is present in excess over the other TRAMP
components and can apparently independently activate
the exosome on some substrates.
Oligo(dT) selection demonstrated that the 30-extended
CTH2 transcripts are polyadenylated, even in the trf4
strain (data not shown). We therefore determined the end
points of the extended transcripts using 30-end RACE on
total RNA extracted from a trf4 strain. PCR products
from the 30 end RACE were cloned in pGEM-T and 10
clones were sequenced. Nine clones identiﬁed 30 ends of
the extended transcripts within a region of 25 nt centred
around 1850-nt 30 to the translation stop codon
(Figure 3D). The sequence ﬂanking these sites also
lacked clear resemblance to consensus mRNA polyade-
nylation signals. The remaining clone terminated 120 nt
closer to the CTH2 ORF (position +1722 relative to the
translation stop codon). The positions of the majority of
the stops would be consistent with the gel migration of the
30-extended CTH2 transcripts, representing the CTH2
ORF (855 nt), together with a 30 UTR of 1.85 kb.
Inspection of the northerns also suggests that there is
some length heterogeneity in the extended CTH2 tran-
scripts, but the positions around +1850 appear to
represent the major 30 ends.
W
T
trf
4D
cth
2D
RT + − + − + −
CTH2
Extended transcript
ADH1
CTH2 CDS CTH2  3′UTR
0 2000nts
NRD1/NAB3
clustersp(A)
Forward Primer
Reverse Primer
A
B
Figure 2. Extended Cth2 transcripts are detected in wild type and trf4
strains. (A) Locations of PCR primers for detection of 30 extended
CTH2 transcripts. (B) Some CTH2 mRNA is not cleaved co-tran-
scriptionally. RT–PCR reactions were performed on RNA samples
from wild-type, trf4 and cth2 strains with PCR primers located on
either side of the CTH2 poly(A) site, and separated on an agarose gel.
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These data indicate that CTH2 mRNA has an unusual
mode of synthesis. The major mRNA species has a
poly(A) tail added at a sequence unrelated to any
characterized polyadenylation site, and appears to be
generated from a long 30 extended species, which is
processed by the nuclear exosome together with Mtr4 and
the TRAMP4 complex.
3’ extendedCTH2 pre-mRNA is a target for Nrd1,
Nab3 and Sen1
Co-transcriptional binding of the Nrd1/Nab3 hetero-
dimer of RNA-binding proteins to nascent transcripts
leads to transcription termination on genes encoding
snRNAs, snoRNAs and cryptic unstable intergenic tran-
scripts (CUTs) (16–20). In addition, Nrd1/Nab3 are
involved in exosome recruitment onto RNA (21) and a
high-throughput screen identiﬁed CTH2 as an mRNA
down-regulated by depletion of Nab3 (22). This sug-
gested that Nrd1/Nab3 might be involved in recruiting
the exosome to the 30-extended CTH2 pre-mRNA.
Inspection of the pre-mRNA sequence revealed multiple
consensus binding sequences for Nrd1 and Nab3 (10
predicted Nrd1 binding sites and 24 Nab3 binding sites)
along the 1.85 kb of the 30-UTR, with two major clusters
centred around positions +720 and +930 relative to the
translation termination codon (Figure 3D).
Expression of the CTH2 mRNA was examined in
strains with ts-lethal mutations in the Nrd1/Nab3 comp-
lex, nrd1-102 and nab3-11. In the nrd1-102 strain, the pre-
CTH2 was mildly accumulated (1.9-fold) following
transfer to 378C, although the mature transcript was still
detected (Figure 4A). In the nab3-11 strain, the phenotype
was more pronounced (5-fold accumulation), with almost
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complete disappearance of the mature mRNA (Figure 4A).
Nrd1 and Nab3 frequently function together with the
RNA helicase Sen1 (16–18,21,23), and a ts-lethal sen1-1
mutant also showed accumulation of the 30-extended pre-
CTH2 at non-permissive temperature (Figure 4B). In
addition to the species corresponding to the 30 ends at
+1850, a shorter extended transcript was observed in the
nrd1, nab3 and sen1 mutants (asterisk in Figure 4A and B).
This species is extended by 150–200 nt and we speculate
that it reﬂects pausing during 30 exonuclease digestion.
To assess processing of the CTH2 30 UTR in the absence
of the remainder of the gene, a 2-kb region was inserted
into a reporter plasmid expressing a well-characterized
mini-PGK1 construct (24,25) under the control of a
doxycyclin-repressible tet07 promoter (Figure 4C). The
reporter also contains a poly(G) cassette, which results in
around 30% inhibition of degradation in the cytoplasm
(26), but it is unclear whether it has any eﬀects in the
nucleus. The reporter generated a prominent transcript
with the gel mobility expected for a species extended to
+1850 (Figure 4D). This was strongly elevated in nrd1-102
and nab3-11 strains, consistent with the model that the
extended CTH2 RNA is a target for Nrd1/Nab3. The level
of the 30-extended PGK1-CTH2 RNA relative to the
‘mature’ RNA was higher in the reporter than for
endogenous CTH2, suggesting that additional features of
the CTH2 sequence and/or genomic context contribute to
the normally very rapid maturation.
ARE-mediated regulation ofCTH2mRNA levels
In human cells, Tis11/TTP is subject to auto-regulation
via an ARE sequence within its 30 UTR (27,28). Inspection
of the 30 UTR of yeast CTH2 revealed a perfect consensus
ARE sequence (UUAUUUAUU) located 50-nt 30 to the
ORF (Figure 1C), suggesting that it too might be subject
to ARE-mediated regulation. To assess this, we tested the
eﬀects of double-point mutations (UUAUUUAUU ->
UUAGGUAUU) in the mini-PGK1 reporter plasmid.
Transcription of the reporter was inhibited and the decay
of the mRNA and 30-extended pre-mRNA was followed
over time. In the strain expressing the reporter with the
double-point mutation (ARE), the levels of both the
mRNA and extended forms of the RNA were elevated
under induced conditions (Figure 5A, 0-min lanes).
Following doxycyclin addition the mRNA carrying the
ARE mutation decayed more slowly (Figure 5A and
quantiﬁed for the mRNA in 5B). We conclude that CTH2
is subject to ARE-mediated decay.
Yeast contains two related proteins Cth1 and Cth2. To
assess whether Cth1 or Cth2 was responsible for targeting
the CTH2 mRNA, the stability of the reporter was
assessed in the cth1 and cth2 single mutants and the
cth1D cth2 double mutant. Over multiple experiments
the reproducibility of the data was poor, presumably due
to subtle diﬀerences in growth conditions and the
complexity of CTH2 regulation. Strains lacking Cth1
showed clearly increased levels of the reporter in some
experiments, but over multiple experiments the data could
not be demonstrated to be statistically signiﬁcant.
In the cytoplasm, ARE-mediated decay can stimulate
both 30 and 50 degradation. In at least some cases, the
largest eﬀect is on 50 degradation, which is performed by
the cytoplasmic 50 to 30 exonuclease Xrn1 (29). We
speculated that the ARE-mediated decay of CTH2
mRNA might be a nuclear event and therefore tested
the eﬀects of mutation of the exclusively nuclear 50 to 30
exonuclease Rat1. For this we made use of the ts-lethal
tap1-1 allele (30) (hereafter referred to as rat1-2). Transfer
of the wild-type strain to 378C led to a 2- fold reduction
in CTH2 levels. In contrast, transfer of the rat1-2 strain to
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non-permissive temperature led to a marked increase in
the level of both the CTH2 mRNA and 3-extended pre-
mRNA (Figure 5C and D). The increase was most marked
30min after transfer and subsequently declined. This
decline may reﬂect the rapid growth inhibition seen in the
rat1-2 strain at non-permissive temperature. Increased
levels of pre-CTH2 and CTH2 RNAs were also seen in
strains carrying MET::rat1 following addition of methio-
nine to the medium (Supplementary Figure S1).
These data indicate that CTH2 is a target for both
ARE-mediated decay and nuclear degradation by Rat1.
DISCUSSION
We have presented several lines of data showing that the
synthesis of CTH2 follows an unusual pathway (Figure 6).
Accumulation of the mRNA is resistant to transfer of the
rna14-1, rna15-2 and pap1 mutant strains to non-
permissive temperature. Indeed, CTH2 mRNA levels
were strikingly increased in rna14-1, rna15-2 and pap1-5
strains at 378C. In these strains, massive nuclear pre-
mRNA degradation is presumably occurring, as the
surveillance machinery attempts to degrade the aberrant
30 extended forms of the products of other protein coding
genes (2). The increased level of CTH2 mRNA may be a
consequence of competition for nuclear surveillance and
degradation systems. This would imply a considerable
level of nuclear degradation of CTH2 mRNA in wild-type
cells. The major site of the poly(A) tails present in
the mature CTH2 mRNA comprised a [GU3–5]5 repeat
element that diﬀers from all previously characterized yeast
polyadenylation sites. Inspection of the yeast genome
revealed the presence of related sequences located 30 to
several other ORFs (data not shown), but the functional
signiﬁcance of these elements has not yet been assessed.
Together, these results indicated that the mature CTH2
mRNA is generated by the processing of a 30-extended
pre-mRNA transcript, followed by polyadenylation that is
not coupled to pre-mRNA cleavage. It seems likely that
related pathways will be used for other genes and in other
eukaryotes.
Processing of the CTH2 pre-mRNA is inhibited by
inhibition of the core exosome or loss of the nuclear-
speciﬁc exosome component Rrp6. Eﬃcient maturation
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also requires the TRAMP4 polyadenylation complex and
the Nrd1/Nab3/Sen1 complex, both of which have
previously been identiﬁed as co-factors for the nuclear
exosome (19–21,31–34). Nrd1 and Nab3 are believed to
bind target RNAs co-transcriptionally, since they can
promote transcription termination on other transcripts
(16,17,19,20). The extended 30-UTR of the CTH2 pre-
mRNA contains numerous potential binding sites for
Nrd1 and Nab3, including two conspicuous clusters. We
predict that the Nrd1/Nab3/Sen1 complex binds the
nascent CTH2 transcript, and recruits the TRAMP4
complex and the nuclear exosome. The exosome then
rapidly degrades the pre-mRNA, soon after transcription
termination generates a free 30 end (Figure 6).
The 30 UTR of CTH2 includes a sequence of 12
adenosine residues (labelled A12 in Figure 1C). We initially
speculated that proteins (e.g. Pab1) bound to the A12
sequence might halt the exosome allowing poly(A) addi-
tion. However, all sequenced CTH2 cDNAs terminated
further 30 than the A12 element. Previous analysis of the
NAB2 gene indicated that the auto-regulation of mRNA
levels involves an encoded A26 sequence (35). Whether the
A12 sequence in CTH2 plays a role in regulation remains
to be determined. We also considered that the Nab4
protein might contribute to halting exonuclease progres-
sion, since a putative binding site (UAUAUA) is located
40-nt 50 to the [GU3–5]5 element. Strains carrying nab4-1,
nab4-4 and nab4-7 mutations did not clearly reduce CTH2
mRNA formation (data not shown), arguing against this
model. However, a caveat is that diﬀerent alleles of NAB4
show distinctly diﬀerent phenotypes (36), so it is con-
ceivable that other alleles would have stronger eﬀects.
A potential explanation is that at least some of the
components of the normal cleavage and polyadenylation
machinery associate with sequences around the [GU3–5]5
element and block progression of the exosome, as
previously proposed for 30 extended pre-mRNAs in
rna14 mutants (2). In the rna14-1 mutant strain, the
CTH2 mRNA lacks a poly(A) tail. This shows that Rna14
is involved in polyadenylation, implying that it is present,
even though it is not required for 30-end formation. The
poly(A) tail is also absent in pap1 mutants, indicating that
the 30-processed CTH2 mRNA is polyadenylated by Pap1.
In yeast, intergenic regions are generally short, and the
extended CTH2 transcripts run through much of the
length of the SLX4 (YLR135W) gene, which is encoded
on the opposite strand. Both polyadenylation site of the
extended transcript and the cluster of Nrd1/Nab3 binding
sites lie within the ORF of SLX4. Comparison of the
locations of the Nrd1/Nab3 binding sites in the CTH2
transcript to the protein-coding capacity of SLX4 yielded
no clear pattern. Some predicted Nrd1/Nab3 binding sites
correspond to evolutionarily conserved amino acids, while
others do not. An obvious diﬃculty in interpretation is
that it is currently unclear whether all of the predicted
Nrd1/Nab3 binding sites actually function in targeting the
transcript for processing. No signiﬁcant alterations in
SLX4 expression were detected in the microarray analyses
of exosome mutants in which increased CTH2 levels were
observed (4).
Regulation ofCTH2 levels
Cth2 is involved in ARE-dependent regulation of mRNA
stability, particularly in the context of Fe deprivation,
allowing coordinated inhibition of the expression of
several genes. The mammalian homologue TTP auto-
regulates its own mRNA via ARE sequences present in its
Poly(A) machinery
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30-UTR (27,28). The 30-UTR of CTH2 mRNA contains a
perfect consensus ARE nonamer (UUAUUUAUU) in a
U-rich environment, located 50 nt after the translation stop
codon. This sequence is functionally important, since a
double-point mutation (UUAGGUAUU) signiﬁcantly
stabilized both the 30 extended and mature forms of a
reporter construct containing the entire 30 ﬂanking region
of CTH2. Cytoplasmic ARE-mediated degradation is
reported to promote mRNA decapping and 50 degradation
by the 50 exonuclease Xrn1 (29). Since all our data
indicated that CTH2 is subject to nuclear processing, we
tested the eﬀects of mutation or depletion of the nuclear 50
exonuclease Rat1. The levels of both pre-CTH2 and CTH2
were rapidly increased by inhibition of Rat1. This suggests
that the ARE stimulates 50-degradation of pre-CTH2 and
CTH2 by Rat1. It was previously reported that deletion
of the gene encoding Cth1, a homologue of Cth2,
up-regulates CTH2 mRNA levels (9), strongly suggesting
that Cth1 participates in the ARE-mediated regulation of
CTH2 mRNA. Consistent with this, we saw increased
levels of the mini-PGK1-CTH2 reporter in strains lacking
Cth1, but the data could not be shown to be statistically
signiﬁcant.
We postulate that CTH2 is subject to ARE-mediated
degradation, possibly mediated by Cth1, and that this
involves the nuclear 50 exonuclease activity of Rat1. The
unusual 30 processing pathway deduced for CTH2mRNA,
may allow time for nuclear surveillance and degradation to
occur on the pre-mRNA, prior to export of the mRNA to
the cytoplasm. The nuclear localization of ARE-mediated
degradation of CTH2 may be important for its physical
and functional separation from the cytoplasmic ARE-
mediated degradation of target RNAs.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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